1. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Issue 1 (December 2016) Authors: Pietrantonio, Filippo; Berenato, Rosa; Maggi, Claudia; Caporale, Marta; Milione, Massimo; Perrone, Federica; Tamborini, Elena; Baratti, Dario; Kusamura, Shigeki; Mariani, Luigi; Niger, Monica; Mennitto, Alessia; Gloghini, Annunziata; Bossi, Ilaria; Settanni, Giulio; Busico, Adele; Bagnoli, Pietro... Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases. Issue 5 (May 2020) Authors: Baratti, Dario; Sammartino, Paolo; Kusamura, Shigeki; Deraco, Marcello; Ansaloni, Luca; Asero, Salvatore; Baiocchi, Gianluca; Bagnoli, Pietro; Cavaliere, Davide; Framarini, Massimo; Cirocchi, Roberto; Coccolini, Federico; Decian, Franco; Delrio, Paolo; Sassaroli, Cinzia; De Simone, Michele; Robel... Journal: European journal of surgical oncology Issue: Volume 46:Issue 5(2020) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗